124 results on '"Inaba, Tomoki"'
Search Results
102. Risk factors for postgastric endoscopic submucosal dissection bleeding in direct oral anticoagulant users.
- Author
-
Kagawa, Tomo, Ishikawa, Shigenao, Hidaka, Yu, Colvin, Hugh Shunsuke, Nakanishi, Akira, Ohkawa, Jumpei, Negishi, Shin, Yasutomi, Eriko, Yamauchi, Kenji, Okamoto, Kunio, Sakakihara, Ichiro, Izumikawa, Koichi, Yamamoto, Kumiko, Takahashi, Sakuma, Tanaka, Shigetomi, Matsuura, Mihoko, Wato, Masaki, Hasui, Toshimi, and Inaba, Tomoki
- Abstract
Objectives Methods Results Conclusions Bleeding after endoscopic submucosal dissection (ESD) for gastric tumors in patients taking antithrombotic drugs, in particular direct oral anticoagulants (DOACs), remains unresolved; therefore, we evaluated the risk factors for post‐ESD bleeding and drug differences in patients taking DOACs.We included 278 patients taking antithrombotic drugs who underwent gastric ESD between January 2017 and March 2022. Antithrombotic drugs were withdrawn following the 2017 guidelines (Appendix on anticoagulants including DOACs). To further clarify differences in antithrombotic agents' effects, the peri‐cancerous mucosa in the resected specimen was pathologically evaluated according to the Updated Sydney System. Multivariate analysis was performed to assess the risk of post‐ESD bleeding.The incidence of post‐ESD bleeding in patients taking DOACs was 19.6% (10/51). Among patients taking antithrombotic drugs, DOACs were identified as a possible factor involved in post‐ESD bleeding (odds ratio [OR] 4.92). Among patients taking DOACs, possible factors included resection length diameter ≥30 mm (OR 3.72), presence of neutrophil infiltration (OR 2.71), lesions occurring in the lower third of stomach (OR 2.34), and preoperative antiplatelet use (OR 2.22). Post‐ESD bleeding by DOAC type was 25.0% of patients (4/16) receiving apixaban, in 20.0% (3/15) receiving edoxaban, in 21.4% (3/14) receiving rivaroxaban, and in none of those receiving dabigatran.The administration of DOACs was shown to be a possible factor involved in post‐ESD bleeding, and risk factors for patients taking DOACs included neutrophil infiltration. The pharmacological differences in the effects of DOACs contributing to bleeding in gastric ulcers suggest comparatively less bleeding with dabigatran after ESD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
103. Stereoconvergent Transformation of 1,2a-Disubstituted Benzo[b]cyclobuta[d]pyrans to 1,3-Disubstituted Tetrahydrodibenzofuran-4-ols and Its Application to the Second-Generation Synthesis of (.+-.)-Linderol A.
- Author
-
Yamashita, Masayuki, Inaba, Tomoki, Shimizu, Takashi, Kawasaki, Ikuo, and Ohta, Shunsaku
- Published
- 2005
- Full Text
- View/download PDF
104. The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5<f>′</f>-deoxy-5-fluorouridine
- Author
-
Nishina, Tomohiro, Hyodo, Ichinosuke, Miyaike, Jiro, Inaba, Tomoki, Suzuki, Seiyuu, and Shiratori, Yasushi
- Subjects
- *
TUMORS , *CANCER cells , *CANCER patients , *ENDOSCOPY , *ANTINEOPLASTIC agents , *IMMUNOSUPPRESSIVE agents - Abstract
The aim of this work was to determine whether intratumour contents of thymidine phosphorylase (TP), which converts 5
′ -deoxy-5-fluorouridine (5′ -DFUR) to 5-fluorouracil, and dihydropyrimidine dehydrogenase (DPD), which degrades 5-fluorouracil to inactive molecules, could be useful in predicting the response of patients with metastatic gastric cancer to chemotherapy using 5′ -DFUR. Endoscopic biopsy specimens for the measurement of TP and DPD were obtained from the primary lesions before the start of combination chemotherapy, in which 5′ -DFUR, cisplatin and mitomycin C were administered. TP and DPD were measured by enzyme-linked immunosorbent assays after the objective responses to chemotherapy had been confirmed. Twenty five patients were enrolled in this study and data for 22 patients in whom responses were confirmed were analysed. The median levels (ranges) of TP and DPD were 80 (4.9–360) and 44 (15–82) U/mg protein, respectively. The median value (range) of TP to DPD ratios was 1.9 (0.25–5.1). Eight patients with a complete or partial response to chemotherapy had significantly higher TP to DPD ratios than did the remaining patients with stable or progressive disease (P=0.014 ). When a cut-off level of TP to DPD ratio was defined as the median value, the high-ratio group (n=11 ) showed a significantly higher response rate (64% vs. 9.1%,P=0.024 ) than the low-ratio group (n=11 ). Overall survival of the high-ratio group was significantly longer than that of the low-ratio group (the median survival time; 300 days vs. 183 days,P=0.047 ). The efficacy of 5′ -DFUR could be optimised by preselecting patients with high TP/ DPD ratios in their tumour tissues, and this would be applicable to the treatment with capecitabine. [Copyright &y& Elsevier]- Published
- 2004
- Full Text
- View/download PDF
105. [Cystic duct carcinoma in a patient with a history of cholecystectomy: a case report].
- Author
-
Sakakihara I, Wato M, Ishihama S, Hugh Colvin S, Kagawa T, Izumikawa K, Takahashi S, Tanaka S, Ishikawa S, and Inaba T
- Subjects
- Male, Humans, Aged, 80 and over, Cystic Duct diagnostic imaging, Cystic Duct surgery, Cystic Duct pathology, Cholecystectomy, Cholangiopancreatography, Endoscopic Retrograde, Cholecystectomy, Laparoscopic, Gallstones pathology, Gallstones surgery, Adenocarcinoma diagnosis
- Abstract
An 83-year-old Japanese man who underwent cholecystectomy for cholecystolithiasis 17 years ago visited our hospital owing to epigastric pain. He was initially diagnosed with choledocholithiasis and acute cholangitis following white blood cell, C-reactive protein, total bilirubin, alkaline phosphatase, and γ-glutamyltranspeptidase level elevations along with common bile duct stones on computed tomography (CT). Moreover, CT, magnetic resonance imaging, endoscopic retrograde cholangiography (ERC), and endoscopic ultrasonography (EUS) also revealed a 2-cm-diameter mass arising from the remnant cystic duct. The cytology of the bile at the time of ERC was not conclusive. However, EUS-assisted fine needle aspiration (EUS-FNA) of the mass confirmed the diagnosis of adenocarcinoma of the remnant cystic duct. The patient underwent extrahepatic bile duct resection. Cystic duct carcinoma following cholecystectomy is rare. We report a case diagnosed by EUS-FNA.
- Published
- 2024
- Full Text
- View/download PDF
106. Long-term outcomes of patients with primary intestinal follicular lymphoma managed with watch-and-wait strategy.
- Author
-
Iwamuro M, Tanaka T, Ennishi D, Matsueda K, Yoshioka M, Miyahara K, Sakaguchi C, Nishimura M, Nagahara T, Mannami T, Takenaka R, Oka S, Inoue M, Takimoto H, Inaba T, Kobayashi S, Toyokawa T, Tsugeno H, Suzuki S, Sawada S, Tanaka S, Tsuzuki T, and Okada H
- Subjects
- Humans, Retrospective Studies, Disease Progression, Lymphoma, Follicular pathology
- Abstract
Patients with primary intestinal follicular lymphoma are often followed-up without a specific treatment, and this approach is called the "watch-and-wait approach." However, the long-term outcomes of this patient group have not been sufficiently investigated. We enrolled patients with primary intestinal follicular lymphoma who were diagnosed before 2016 and managed with the watch-and-wait approach in 20 institutions. We retrospectively investigated the overall, disease-specific, and event-free survival rates as well as the rate of spontaneous regression. Among the 248 patients with follicular lymphoma with gastrointestinal involvement, 124 had localized disease (stage I or II
1 ). We analyzed the data of 73 patients who were managed using the watch-and-wait approach. During the mean follow-up period of 8.3 years, the follicular lymphoma had spontaneously resolved in 16.4% of the patients. The 5-year and 10-year overall survival rates were 92.9% and 87.1%, respectively. With disease progression (n = 7), initiation of therapy (n = 7), and histologic transformation to aggressive lymphoma (n = 0) defined as events, the 5-year and 10-year event-free survival rates were 91.1% and 86.9%, respectively. No patient died of progressive lymphoma. Thus, both 5-year and 10-year disease-specific survival rates were 100%. In conclusion, an indolent long-term clinical course was confirmed in the patients with primary intestinal follicular lymphoma. The watch-and-wait strategy is a reasonable approach for the initial management of these patients., (© 2023. The Author(s).)- Published
- 2023
- Full Text
- View/download PDF
107. Effectiveness of second-look endoscopy after gastric endoscopic submucosal dissection in patients taking antithrombotic agents: a multicenter propensity score matching analysis.
- Author
-
Iwatsubo T, Takeuchi T, Hakoda A, Fujiwara Y, Nagami Y, Naito Y, Dohi O, Tatsuta T, Sawaya M, Jin X, Koike T, Sugimoto M, Murata M, Hamada K, Okada H, Kobara H, Chiyo T, Yoshida N, Tomatsuri N, Inaba T, Ishikawa S, Nagahara A, Ueyama H, Koizumi E, Iwakiri K, Mizukami K, Murakami K, Furuta T, Suzuki T, Ogasawara N, Kasugai K, Isomoto H, Kawaguchi K, Shibagaki K, Kataoka H, Shimura T, Suzuki H, Nishizawa T, and Higuchi K
- Subjects
- Fibrinolytic Agents adverse effects, Gastric Mucosa surgery, Humans, Postoperative Hemorrhage epidemiology, Postoperative Hemorrhage etiology, Postoperative Hemorrhage prevention & control, Propensity Score, Prospective Studies, Retrospective Studies, Risk Factors, Endoscopic Mucosal Resection adverse effects, Stomach Neoplasms complications, Stomach Neoplasms surgery
- Abstract
Background: The risk of bleeding after gastric endoscopic submucosal dissection (ESD) in antithrombotic agent users has increased, and its management remains a problem. Second-look endoscopy (SLE) following gastric ESD in antithrombotic agent users may be effective in preventing delayed bleeding, but this requires elucidation. Therefore, this study aimed to investigate the efficacy of SLE in reducing bleeding after gastric ESD in patients receiving antithrombotic agents., Methods: This retrospective cohort study was conducted at 19 referral hospitals in Japan. A total of 1,245 patients who were receiving antithrombotic agents underwent gastric ESD between January 2013 and July 2018. The incidence of delayed bleeding was compared between SLE and non-SLE groups using propensity score matching analysis., Results: Overall, 858 patients (SLE group, 657 patients; non-SLE group, 201 patients) were analyzed. After matching, 198 pairs were created. Delayed bleeding occurred in 10 patients (5.1%) in the SLE group and 16 patients (8.1%) in the non-SLE group [odds ratio (OR) 0.605, 95% confidence interval (CI) 0.23-1.46, p = 0.310]. In the subgroup analysis, SLE reduced the incidence of delayed bleeding in patients receiving heparin bridging therapy (6.3% and 40.0%, respectively; p = 0.004). In the SLE group, prophylactic coagulation did not significantly reduce delayed bleeding compared to the no treatment group (14.6% and 8.6%, respectively; p = 0.140)., Conclusions: SLE was ineffective in reducing bleeding after gastric ESD in antithrombotic agent users, overall. A prospective comparative study is warranted to definitively evaluate the effectiveness of SLE in reducing bleeding in high-risk patients., (© 2022. The Author(s) under exclusive licence to The International Gastric Cancer Association and The Japanese Gastric Cancer Association.)
- Published
- 2022
- Full Text
- View/download PDF
108. Risk factors and prediction of bleeding after gastric endoscopic submucosal dissection in patients on antithrombotic therapy: newly developed bleeding prediction application software, SAMURAI model.
- Author
-
Hakoda A, Takeuchi T, Kojima Y, Fujiwara Y, Nagami Y, Naito Y, Fukuda S, Koike T, Sugimoto M, Hamada K, Kobara H, Yoshida N, Inaba T, Nagahara A, Koizumi E, Murakami K, Furuta T, Ogasawara N, Isomoto H, Shibagaki K, Kataoka H, Suzuki H, and Higuchi K
- Abstract
Bleeding after gastric endoscopic submucosal dissection (ESD) remains problematic, especially in patients receiving antithrombotic therapy. Therefore, this study aimed to identify the risk factors. In this retrospective study, patients ( n = 1,207) who underwent gastric ESD while receiving antithrombotic therapy were enrolled at Osaka Medical and Pharmaceutical University Hospital and 18 other referral hospitals in Japan. Risks of post-ESD bleeding were calculated using multivariable logistic regression. The dataset was divided into a derivation cohort and a validation cohort. We created a prediction model using the derivation cohort. The accuracy of the model was evaluated using the validation cohort. Post-ESD bleeding occurred in 142 (11.8%) participants. Multivariable analysis yielded an odds ratio of 2.33 for aspirin, 4.90 for P2Y12 receptor antagonist, 1.79 for cilostazol, 0.95 for other antithrombotic agents, 6.53 for warfarin, 5.65 for dabigatran, 7.84 for apixaban, 10.45 for edoxaban, 6.02 for rivaroxaban, and 1.46 for heparin bridging. The created prediction model was called safe ESD management using the risk analysis of post-bleeding in patients with antithrombotic therapy (SAMURAI). This model had good predictability, with a C-statistic of 0.77. In conclusion, use of the SAMURAI model will allow proactive management of post-ESD bleeding risk in patients receiving antithrombotic therapy., Competing Interests: No potential conflicts of interest were disclosed., (Copyright © 2022 JCBN.)
- Published
- 2022
- Full Text
- View/download PDF
109. [Clinical study of sigmoid volvulus at eleven core hospitals in the Kagawa Prefecture].
- Author
-
Wato M, Kawai Y, Inaba T, Kinekawa F, Yasuhara H, Kobayashi M, Oryu M, Hayashi T, Inoue H, Tanaka I, Okano K, and Shibatouge M
- Subjects
- Aged, Aged, 80 and over, Colon, Sigmoid, Endoscopy, Female, Hospitals, Humans, Male, Retrospective Studies, Intestinal Volvulus diagnostic imaging, Intestinal Volvulus epidemiology, Intestinal Volvulus surgery, Sigmoid Diseases epidemiology, Sigmoid Diseases surgery
- Abstract
We analyzed the clinical features of 157 patients admitted to 11 institutions in the Kagawa Prefecture for volvulus of the sigmoid colon. The following were the background information of the patients:median age, 79.0 years;male-to-female ratio, 102:55;median body mass index, 20.0kg/m
2 ;and the proportion of patients with performance status ≥3, 43.9%. Abdominal bloating and pain were the chief complaints. During hospitalization, endoscopy and endoscopic detorsion were performed 157 and 100 times, respectively. An accidental complication was observed in 3 cases, all of which were intestinal perforations. Surgery, which was indicated for ischemia, was performed in 62 of the 157 cases. Endoscopy is useful in the diagnosis of ischemia, which can be treated following an early diagnosis. Of the 157 patients, 19 died, whereas the rest were discharged. The risk factors for death were age ≥80 years and creatinine kinase level ≥200IU/L.- Published
- 2021
- Full Text
- View/download PDF
110. [A case report of Legionella pneumonia in a patient with ulcerative colitis undergoing remission maintenance using azathioprine].
- Author
-
Hirano Y, Takahashi S, Inaba T, Kawai Y, Sakakihara I, Izumikawa K, Yamamoto K, Tanaka S, Ishikawa S, and Wato M
- Subjects
- Aged, Azathioprine adverse effects, Humans, Immunosuppressive Agents adverse effects, Male, Colitis, Ulcerative drug therapy, Legionella, Pneumonia
- Abstract
A 67-year-old man was diagnosed with ulcerative colitis one year ago. Remission was induced via the oral administration of prednisolone and azathioprine;prednisolone was gradually reduced and discontinued. He maintained remission with azathioprine but developed fever and general malaise and visited the Kagawa Prefectural Central Hospital. Chest radiography and a urinary antigen test revealed Legionella pneumonia. His symptoms reduced immediately after the initiation of levofloxacin. Azathioprine suppresses cellular immunity and may increase the risk of Legionella pneumonia.
- Published
- 2020
- Full Text
- View/download PDF
111. [A case of small intestinal ulcer caused by non-steroidal anti-inflammatory drugs patch].
- Author
-
Aoyama Y, Takahashi S, Inaba T, Izumikawa K, and Nakamura S
- Subjects
- Aged, Humans, Intestinal Diseases diagnosis, Intestinal Mucosa, Intestine, Small, Male, Ulcer, Anti-Inflammatory Agents, Non-Steroidal adverse effects, Capsule Endoscopy, Intestinal Diseases chemically induced
- Abstract
A ring-shaped ulcer was observed in the ileum of a 70-year-old male patient with capsule endoscopy of the small intestine performed for detailed investigation of black stools and iron deficiency anemia. Non-steroidal anti-inflammatory drugs (NSAIDs) use in patch form was considered as the etiology. The NSAIDs patches were discontinued, and protective therapy for small intestinal mucosa was initiated. The anemia improved;however, ileus originating from the site of the ulcer required surgical resection. The resected specimen showed no specific pathological findings. Based on the clinical findings, the patient was diagnosed with NSAIDs-induced small intestinal ulcer. The use of NSAIDs patches should be considered as a potential cause of injury to gastrointestinal mucosa.
- Published
- 2019
- Full Text
- View/download PDF
112. [A case of metastatic prostate cancer with gastric metastases and high serum CEA].
- Author
-
Aoyama Y, Wato M, Colvin M, Nakamura S, Ishikawa S, and Inaba T
- Subjects
- Aged, Carcinoembryonic Antigen, Humans, Liver Neoplasms diagnosis, Lymphatic Metastasis, Male, Prostatic Neoplasms pathology, Stomach Neoplasms diagnosis, Liver Neoplasms secondary, Prostatic Neoplasms diagnosis, Stomach Neoplasms secondary
- Abstract
A 74-year-old male who was receiving endocrine therapy for prostate cancer, with multiple bone and lymph node metastases (T2bN1M1 Stage D2), underwent follow-up computed tomography (CT). The CT revealed multiple liver metastases, a high serum CEA level, and an unchanged PSA level. Upper gastrointestinal endoscopy showed an elevated lesion with mucosal erosion on the lesser curvature of the middle gastric corpus, revealed to be a metastatic prostate cancer lesion following immunohistochemical confirmation. This case demonstrates the potential for gastric metastases in patients with advanced prostate cancer and high serum CEA levels.
- Published
- 2018
- Full Text
- View/download PDF
113. A case of pancreatic mucinous cystic neoplasm that enlarged during pregnancy and was resected after childbirth.
- Author
-
Takashima S, Wato M, Inaba T, Mizukawa S, Izumikawa K, Ishikawa S, Miyoshi M, and Kawai K
- Abstract
A 28-year-old pregnant woman presented with an abdominal mass at 12 weeks' gestation. Magnetic resonance imaging revealed a 7 cm cystic lesion arising extrinsically from the pancreatic head, which was diagnosed as a mucinous cystic neoplasm. Although we recommended surgical excision during the second trimester, the patient refused the procedure and chose to continue her pregnancy. We monitored the lesion and noted that it gradually grew to 13 cm over the course of the pregnancy. Subsequently, we enucleated it after childbirth. Histopathological examination was compatible with high-grade dysplasia and confirmed the diagnosis of mucinous cystadenoma of the pancreas.
- Published
- 2014
114. [Two cases of dabigatran-induced esophageal ulcer indicating the usefulness of drug administration guidance].
- Author
-
Izumikawa K, Inaba T, Mizukawa S, Kawai Y, Sakakihara I, Ishikawa S, Miyoshi M, Wato M, and Kawai K
- Subjects
- Aged, Aged, 80 and over, Dabigatran, Female, Humans, Male, beta-Alanine administration & dosage, beta-Alanine adverse effects, Antithrombins administration & dosage, Antithrombins adverse effects, Benzimidazoles administration & dosage, Benzimidazoles adverse effects, Esophageal Diseases chemically induced, Ulcer chemically induced, beta-Alanine analogs & derivatives
- Abstract
Here we report two cases of dabigatran-induced esophageal ulcer. Case 1 was a 67-year-old man who presented with heartburn that developed a month after dabigatran administration. Case 2 was an 81-year-old woman who presented with epigastralgia that developed within a few days of dabigatran administration. Endoscopic findings were similar in both cases, including shallow esophageal ulcers covered with a thin whitish membrane. The patients were advised to consume the drug with plenty of water during meals and to remain in a sitting position for 30 min after consumption. This method successfully decreased their symptoms and ulcers, indicating that drug administration guidance is extremely effective in managing dabigatran-induced esophageal injury.
- Published
- 2014
115. [Present status of gastrointestinal damage due to non-steroidal anti-inflammatory drugs (NSAIDs)].
- Author
-
Inaba T, Ishikawa S, Miyoshi M, and Kurahara K
- Subjects
- Gastrointestinal Hemorrhage prevention & control, Humans, Inflammation drug therapy, Intestinal Mucosa physiopathology, Risk Factors, Ulcer prevention & control, Anti-Inflammatory Agents, Non-Steroidal adverse effects, Gastrointestinal Hemorrhage chemically induced, Intestinal Mucosa pathology, Ulcer chemically induced
- Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) are roughly divided into a low-dose aspirin group used for primary and secondary prevention of cardiovascular events and non-aspirin NSAIDs used for treatment of bone and joint diseases. Both cause gastrointestinal damage directly or indirectly. In the present study, we reviewed gastrointestinal damage due to non-aspirin NSAIDs with respect to the esophagus, stomach/duodenum, small intestine and colon. Damage due to NSAIDs occurs in all digestive tracts and since the analgesic effect of NSIADs hides subjective symptoms, the symptoms are often not treated until they are advanced to a serious state. Further, patients receiving NSAIDs are mostly elderly and have complications so that the onset of the conditions is serious and prevention is important. It is necessary to investigate a method that is effective for preventing damage for all digestive tracts and the mechanisms of damage must be understood for this reason.
- Published
- 2013
116. Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement.
- Author
-
Iwamuro M, Okada H, Takata K, Shinagawa K, Fujiki S, Shiode J, Imagawa A, Araki M, Morito T, Nishimura M, Mizuno M, Inaba T, Suzuki S, Kawai Y, Yoshino T, Kawahara Y, Takaki A, and Yamamoto K
- Subjects
- Adult, Aged, Chi-Square Distribution, Endoscopy, Gastrointestinal, Feasibility Studies, Female, Gastrointestinal Neoplasms pathology, Humans, Japan, Lymphoma, Follicular pathology, Male, Middle Aged, Neoplasm Staging, Predictive Value of Tests, Retrospective Studies, Fluorodeoxyglucose F18, Gastrointestinal Neoplasms diagnostic imaging, Lymphoma, Follicular diagnostic imaging, Positron-Emission Tomography, Radiopharmaceuticals
- Abstract
Aim: To investigate the capacity for 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) to evaluate patients with gastrointestinal lesions of follicular lymphoma., Methods: This retrospective case series consisted of 41 patients with follicular lymphoma and gastrointestinal involvement who underwent 18F-FDG-PET and endoscopic evaluations at ten different institutions between November 1996 and October 2011. Data for endoscopic, radiological, and biological examinations performed were retrospectively reviewed from clinical records. A semi-quantitative analysis of 18F-FDG uptake was performed for each involved area by calculating the maximum standardized uptake value (SUVmax). Based on the positivity of 18F-FDG uptake in the gastrointestinal lesions analyzed, patients were subdivided into two groups. To identify potential predictive factors for 18F-FDG positivity, these two groups were compared with respect to gender, age at diagnosis of lymphoma, histopathological grade, pattern of follicular dendritic cells, mitotic rate, clinical stage, soluble interleukin-2 receptor levels detected by 18F-FDG-PET, lactate dehydrogenase (LDH) levels, hemoglobin levels, bone marrow involvement, detectability of gastrointestinal lesions by computed tomography (CT) scanning, and follicular lymphoma international prognostic index (FLIPI) risk., Results: Involvement of follicular lymphoma in the stomach, duodenum, jejunum, ileum, cecum, colon, and rectum was identified in 1, 34, 6, 3, 2, 3, and 6 patients, respectively. No patient had esophageal involvement. In total, 19/41 (46.3%) patients exhibited true-positive 18F-FDG uptake in the lesions present in their gastrointestinal tract. In contrast, false-negative 18F-FDG uptake was detected in 24 patients (58.5%), while false-positive 18F-FDG uptake was detected in 5 patients (12.2%). In the former case, 2/19 patients had both 18F-FDG-positive lesions and 18F-FDG-negative lesions in the gastrointestinal tract. In patients with 18F-FDG avidity, the SUVmax value of the involved gastrointestinal tract ranged from 2.6 to 17.4 (median: 4.7). For the 18F-FDG-negative (n = 22) and -positive (n = 19) groups, there were no differences in the male to female ratios (10/12 vs 4/15, P = 0.186), patient age (63.6 ± 2.4 years vs 60.1 ± 2.6 years, P = 0.323), presence of histopathological grade 1 vs 2 (20/2 and 17/2, P = 1.000), follicular dendritic cell pattern (duodenal/nodal: 13/5 vs 10/3, P = 1.000), mitotic rate (low/partly high, 14/1 vs 10/3, P = 0.311), clinical stage according to the Ann Arbor system (stages IE and IIE/other, 15/7 vs 15/4, P = 0.499), clinical stage according to the Lugano system (stages I and II-1/other, 14/8 vs 14/5, P = 0.489), soluble interleukin-2 receptor levels (495 ± 78 vs 402 ± 83, P = 0.884), LDH levels (188 ± 7 vs 183 ± 8, P = 0.749), hemoglobin levels (13.5 ± 0.3 vs 12.8 ± 0.4, P = 0.197), bone marrow involvement (positive/negative, 1/8 vs 1/10, P = 1.000), detectability by CT scanning (positive/negative, 1/16 vs 4/13, P = 0.335), and FLIPI risk (low risk/other, 16/6 vs 13/6, P = 0.763), respectively in each case., Conclusion: These findings indicate that it is not feasible to predict 18F-FDG-avidity. Therefore, 18F-FDG-PET scans represent a complementary modality for the detection of gastrointestinal involvements in follicular lymphoma patients, and surveillance of the entire gastrointestinal tract by endoscopic examinations is required.
- Published
- 2012
- Full Text
- View/download PDF
117. Characteristics of serious complicated gastroduodenal ulcers in Japan.
- Author
-
Ishikawa S, Inaba T, Mizuno M, Miyake Y, Okada H, Ishikawa H, Hori K, Wato M, Kawai K, and Yamamoto K
- Subjects
- Aged, Aged, 80 and over, Chi-Square Distribution, Comorbidity, Female, Helicobacter Infections complications, Helicobacter Infections microbiology, Helicobacter pylori isolation & purification, Humans, Japan epidemiology, Male, Middle Aged, Multivariate Analysis, Odds Ratio, Peptic Ulcer microbiology, Peptic Ulcer mortality, Peptic Ulcer pathology, Peptic Ulcer Hemorrhage microbiology, Peptic Ulcer Hemorrhage mortality, Peptic Ulcer Hemorrhage pathology, Prospective Studies, Risk Assessment, Risk Factors, Time Factors, Anti-Inflammatory Agents, Non-Steroidal adverse effects, Peptic Ulcer chemically induced, Peptic Ulcer Hemorrhage chemically induced
- Abstract
Background/aims: Even in Japan where the incidence of H. pylori infection is high, patients with gastroduodenal ulcers caused by NSAIDs are on the increase. A prospective study was conducted to elucidate the characteristics of gastroduodenal ulcers complicated with ulcerous hemorrhage and perforation among Japanese., Methodology: The subjects were 305 consecutive cases with hemorrhaging ulcers and 76 consecutive cases with perforated ulcers basis at Kagawa Prefectural Central Hospital between January 2000 and December 2008. These subjects were divided into 3 groups (lowdose aspirin, non-aspirin NSAIDs and non-NSAIDs) and were further stratified by the presence of an H. pylori infection., Results: The 76 perforating ulcers were composed of 54 non-NSAIDs ulcers and 22 NSAIDs-related ulcers. The 305 hemorrhaging ulcers were composed of 156 non-NSAIDs ulcers, 94 non-aspirin NSAIDs ulcers and 55 on low-dose aspirin. The mortality for the non-aspirin NSAIDs group (12.8%, 12/94) and for the low-dose aspirin group (10.9%, 6/55) was significantly higher (p<0.01 and p<0.05, respectively) than the corresponding figure (2.6%, 4/156) for the non-NSAIDs group. The causes of death were exacerbation of or complications from the background diseases (Charlson Co-morbidity Index 3≤) (Odds ratios (OR) 6.01, 95% CI (1.98-18.89))., Conclusions: Approximately 50% of the gastroduodenal ulcers with complications found in Japanese are NSAIDs-related and may take a fatal turn. It is necessary to take measures to prevent the complicated ulcers corresponding to risk factors such as the severity of background diseases.
- Published
- 2012
- Full Text
- View/download PDF
118. Triple therapy with ecabet sodium, amoxicillin and lansoprazole for 2 weeks as the rescue regimen for H. pylori infection.
- Author
-
Furuta T, Kato M, Sugimoto M, Sasaki M, Kamoshida T, Furukawa K, Inaba T, Tomita T, Shirai T, Ishii N, Nomura H, Konda Y, and Asaka M
- Subjects
- Anti-Bacterial Agents administration & dosage, Clarithromycin administration & dosage, Drug Resistance, Bacterial, Drug Therapy, Combination, Female, Helicobacter Infections microbiology, Humans, Lansoprazole, Male, Metronidazole administration & dosage, Middle Aged, Proton Pump Inhibitors administration & dosage, Treatment Failure, 2-Pyridinylmethylsulfinylbenzimidazoles administration & dosage, Abietanes administration & dosage, Amoxicillin administration & dosage, Helicobacter Infections drug therapy, Helicobacter pylori drug effects
- Abstract
Background/aim: Ecabet sodium has an anti-H. pylori effect. We assessed the efficacy of ecabet sodium in the rescue therapy for the eradication of H. pylori., Methods: A total of 74 patients with failed eradication of H. pylori after triple therapy with lansoprazole 30 mg bid, amoxicillin 750 mg bid and clarithromycin 200 mg bid were enrolled. They were randomly assigned to the three treatment groups as follows: LAC, lansoprazole 30 mg + amoxicillin 750 mg + clarithromycin 200 mg bid for 1 week; LAC2E, lansoprazole 30 mg bid + amoxicillin 750 mg bid + clarithromycin 200 mg bid + ecabet sodium 2 g bid for 1 week; and LA2E, lansoprazole 30 mg bid + amoxicillin 750 mg bid + ecabet sodium 2 g bid for 2 weeks. Eradication of H. pylori was assessed by the 13C-urea breath test after treatment., Results: Eradication rates in intention-to-treat and per-protocol analyses were 20.0% (95% CI: 6.8-40.7) and 20.0% (6.8-40.7) with LAC, respectively, and 16.0% (4.5-36.1) and 17.4% (5.0-38.8) with LAC2E. In contrast, respective rates with LA2E were 75% (53.3-90.2) and 85.7% (63.7-97.0), which were significantly higher than those with LAC (p<0.001 for both ITT and PP) and LAC2E (p<0.001 for both ITT and PP)., Conclusion: Triple therapy with ecabet sodium, lansoprazole and amoxicillin for 2 weeks was effective as the rescue therapy after failure of the standard clarithromycin-based regimen.
- Published
- 2011
- Full Text
- View/download PDF
119. [A case of hemolytic uremic syndrome after adjuvant chemotherapy with gemcitabine in a patient with pancreatic cancer].
- Author
-
Wato M, Inaba T, Ishikawa H, Ishikawa S, Baba N, Miyoshi M, Senoh T, Nagano T, Takaguchi K, Watanabe S, and Kawai K
- Subjects
- Chemotherapy, Adjuvant adverse effects, Deoxycytidine adverse effects, Humans, Male, Middle Aged, Gemcitabine, Antimetabolites, Antineoplastic adverse effects, Deoxycytidine analogs & derivatives, Hemolytic-Uremic Syndrome chemically induced, Pancreatic Neoplasms drug therapy
- Abstract
A 63-year-old man with Stage IVa pancreas tail cancer was admitted for a distal pancreatectomy and splenectomy; adjuvant chemotherapy with gemcitabine was also administered. The chemotherapy was terminated after 16 courses due to hemolytic anemia, thrombocytopenia and renal dysfunction. Plasma exchange was performed; however the patient's renal function was diminished, requiring chronic hemodialysis. Physicians should be cautious of hemolytic uremic syndrome as a possible adverse reaction to gemcitabine and be aware that tests are needed for its early detection.
- Published
- 2010
120. Basal protrusion of ulcers induced by endoscopic submucosal dissection (ESD) during treatment with proton pump inhibitors, and the suppressive effects of polaprezinc.
- Author
-
Inaba T, Ishikawa S, Toyokawa T, Ishikawa H, Miyahara K, Wato M, Kawai K, Okada H, and Yamamoto K
- Subjects
- 2-Pyridinylmethylsulfinylbenzimidazoles administration & dosage, Aged, Carnosine administration & dosage, Carnosine therapeutic use, Cytoprotection, Drug Therapy, Combination, Female, Humans, Lansoprazole, Male, Middle Aged, Organometallic Compounds administration & dosage, Stomach Ulcer etiology, Stomach Ulcer pathology, Wound Healing, Zinc Compounds administration & dosage, Zinc Compounds therapeutic use, 2-Pyridinylmethylsulfinylbenzimidazoles therapeutic use, Carnosine analogs & derivatives, Gastric Mucosa surgery, Organometallic Compounds therapeutic use, Postoperative Complications drug therapy, Proton Pump Inhibitors therapeutic use, Stomach Neoplasms surgery, Stomach Ulcer drug therapy
- Abstract
Background/aims: When a peptic ulcer is treated with proton pump inhibitors (PPI), protrusion of the ulcer base is sometimes noted during ulcer healing. To clarify the incidence of ulcer base protrusion in ulcers induced by endoscopic submucosal dissection (ESD), and whether the addition of polaprezinc, a cytoprotective agent used for treatment of gastric ulcer, to the PPI regimen helps to suppress it., Methodology: One hundred sixty-three patients on which ESD was performed were randomly allocated to either two groups: one treated with lansoprazole (30mg/day) and the other with lansoprazole (30mg/day) plus polaprezinc (150mg/day) for the treatment of ESD-induced ulcer. The condition of the ESD-induced ulcer was blindly assessed two months after ESD by two physicians., Results: Lansoprazole plus polaprezinc group showed significantly better ulcer healing (p < 0.0001) and protrusion of the ulcer base was recognized in only 1.3% (1/77), an incidence significantly lower than that in lansoprazole group (20.7%, 16/77, p = 0.0001). Polaprezinc was the only significant factor (p = 0.0001) differentiating patients who had ulcer base protrusion (n = 17) from those who did not (n = 137)., Conclusions: Polaprezinc prevents protrusion of the ulcer base during the healing of ESD-induced ulcer with PPI.
- Published
- 2010
121. Incidence of serious upper gastrointestinal bleeding in patients taking non-steroidal anti-inflammatory drugs in Japan.
- Author
-
Ishikawa S, Inaba T, Mizuno M, Okada H, Kuwaki K, Kuzume T, Yokota H, Fukuda Y, Takeda K, Nagano H, Wato M, and Kawai K
- Subjects
- Adult, Aged, Aged, 80 and over, Anti-Inflammatory Agents, Non-Steroidal administration & dosage, Aspirin administration & dosage, Aspirin adverse effects, Cohort Studies, Duodenal Ulcer chemically induced, Duodenal Ulcer epidemiology, Female, Follow-Up Studies, Histamine H2 Antagonists therapeutic use, Humans, Incidence, Japan epidemiology, Male, Medical Records, Middle Aged, Proton Pump Inhibitors therapeutic use, Anti-Inflammatory Agents, Non-Steroidal adverse effects, Peptic Ulcer Hemorrhage chemically induced, Peptic Ulcer Hemorrhage epidemiology, Stomach Ulcer chemically induced, Stomach Ulcer epidemiology
- Abstract
Upper gastrointestinal bleeding is a major adverse event of non-steroidal anti-inflammatory drugs (NSAIDs), and co-administration of proton pump inhibitors and H2 receptor antagonists has been established as a means of preventing such an effect. However, the incidence of bleeding associated with NSAID-induced ulcers under conditions where such strong anti-acid agents are used for prevention has yet to be clarified. We aimed to determine the annual incidence of serious upper gastrointestinal ulcer bleeding among Japanese patients in whom NSAIDs were used in our hospital. Before commencing the study, we recommended to all the physicians in our hospital the best method for caring for NSAID users, focusing on the concomitant use of proton pump inhibitors or H2 receptor antagonists. We conducted a cohort study involving 17,270 patients for whom NSAIDs had been newly prescribed. Bleeding from gastric ulcers was observed in 8 of the 17,270 patients using NSAIDs (0.05%). The pooled incidence rate for bleeding was calculated as 2.65 (95% confidence interval, 2.56-2.74) and 1.29 (1.27-1.31) per 1,000 patient years for low-dose aspirin and non-aspirin NSAID users, respectively. None of the bleeding ulcer patients required blood transfusion or were in serious condition. In conclusion, gastric ulcer bleeding occurred in low-dose aspirin or non-aspirin NSAID users, but its incidence was low and outcomes were not serious when adequate preventive measures were taken.
- Published
- 2008
- Full Text
- View/download PDF
122. [A case of gastric arteriovenous malformation forming faded depression].
- Author
-
Wato M, Inaba T, Ishikawa S, Takaguchi K, Kita K, and Kawai K
- Subjects
- Arteriovenous Malformations complications, Gastroscopy, Humans, Male, Middle Aged, Stomach diagnostic imaging, Ultrasonography, Arteriovenous Malformations pathology, Gastrointestinal Hemorrhage etiology, Stomach blood supply, Stomach pathology
- Abstract
A 48-year-old man was referred to our hospital because of anemia. Upper gastrointestinal endoscopy showed discolored depressive lesion like gastric cancer, 30mm in diameter, in the greater curvature of the upper gastric body. During the endoscopic examination, pulsative bleeding from the lesion was occurred and we performed clipping hemostasis. We diagnosed a gastric arteriovenous malformation by endoscopic ultrasonograph and angiography. A pylorus preserving-gastrectomy was performed and Pathohistological examination revealed arterio-venous connection in the submucosal layer of the gastric wall.
- Published
- 2006
123. Novel stereoconvergent transformation of 1,2a-disubstituted 1,2,2a,8b-tetrahydro-3H-benzo[b]cyclobuta[d]pyran-3-ones to 1,3-disubstituted 1,2,4a,9b-tetrahydrodibenzofuran-4-ols and its application to the second-generation synthesis of (+/-)-linderol A.
- Author
-
Yamashita M, Inaba T, Nagahama M, Shimizu T, Kosaka S, Kawasaki I, and Ohta S
- Subjects
- Magnetic Resonance Spectroscopy, Models, Molecular, Spectrometry, Mass, Electrospray Ionization, Benzofurans chemical synthesis, Benzofurans chemistry, Pyrans chemistry
- Abstract
1,2a-Disubstituted 1,2,2a,8b-tetrahydro-3H-benzo[b]cyclobuta[d]pyran-3-ones bearing an electron-withdrawing group at the 2a-position were treated with two equivalents of dimethylsulfoxonium methylide to give r-1,t-4a,t-9b-1,3-disubstituted 1,2,4a,9b-tetrahydrodibenzofuran-4-ols stereoconvergently regardless of the stereochemistry of the 1-position on the benzocyclobutapyran ring. This methodology was applied to the second-generation synthesis of (+/-)-linderol A, a melanin biosynthesis inhibitory natural product.
- Published
- 2005
- Full Text
- View/download PDF
124. [Effect of antiulcer agents on the urea breath test--Comparison between rebamipide and ecabet sodium].
- Author
-
Inaba T, Mizuno M, Kawai K, Takaguchi K, Yoshida Y, Kita K, Okada H, and Tsuji T
- Subjects
- False Negative Reactions, Female, Helicobacter Infections diagnosis, Helicobacter pylori, Humans, Male, Middle Aged, Predictive Value of Tests, Abietanes, Alanine analogs & derivatives, Alanine pharmacology, Anti-Ulcer Agents pharmacology, Breath Tests, Diterpenes pharmacology, Quinolones pharmacology, Urea analysis
- Abstract
In this study, we assessed whether standard doses of antiulcer drugs rebamipide, and ecabet sodium influence the accuracy of the urea breath test (UBT). Without medication, values of UBT estimated with nondispersive isotope-selective infrared spectrometry did not significantly change during follow-up (average 4.4 months). Then, we randomized 21 H. pylori-positive patients without serious disease to receive either rebamipide or ecabet sodium for 28 days. UBT was performed at baseline, on day 14, on day 28, and 2 weeks after cessation of drugs. On day 14, the median value of UBT declined significantly (p = 0.0113) compared to baseline with ecabet sodium but not with rebamipide. This caused a false-negative result of UBT in one of 11 patients who received ecabet sodium. The decline of UBT resolved 2 weeks after drug cessation. In addition, we performed a crossover study in 11 H. pylori-positive volunteers with these drugs, and ecabet sodium but not rebamipide significantly reduced UBT values (p = 0.0058). These findings indicate that ecabet sodium adversely influences the accuracy of UBT and that the withdrawal of this drug before testing appears to be necessary to avoid false-negative results.
- Published
- 2002
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.